Cervical cancer screening

Foreword
Introduction
Summary of recommendations
1. Cervical cancer in Australia
2. The rationale for primary HPV screening
3. Terminology
- Introduction
- HPV testing terminology
- Cytology and AMBS 2004 terminology for reporting cervical cytology
- Preparation of cervical screening reports
- Colposcopy terminology
- Histopathology
- Supplement. Sample reports
4. Unsatisfactory cervical screening results
5. Benefits, harms and cost-effectiveness of cervical screening in the renewed NCSP
6. Management of oncogenic HPV test results
- Introduction
- MSAC recommendations
- Oncogenic HPV types not detected
- Oncogenic HPV types 16 and/or 18
- HPV oncogenic types not 16/18
- Self-collected vaginal samples
- Women undergoing exit testing
- Screening in women older than 75
- Discussion
7. Colposcopy
- Introduction
- Colposcopy terminology
- Principles of practice
- History, examination and investigation
- Treatment
- Colposcopy data for the National Cancer Screening Register
- Quality improvement in colposcopy
- Supplement. Colposcopy information for discussion with patient
- Supplement. Colposcopy technologies and documentation
8. Management of discordant colposcopic impression, histopathology and referral LBC prediction
- Background
- Normal colposcopic findings following LBC prediction of LSIL or HSIL
- Type 3 TZ (unsatisfactory) colposcopy following LBC prediction of LSIL or HSIL
- Discussion
9. Management of histologically confirmed low-grade squamous abnormalities
10. Management of histologically confirmed high-grade squamous abnormalities
- Introduction
- Diagnosis of HSIL
- Treatment of HSIL
- Test of Cure after treatment for HSIL (CIN2/3)
- Discussion
11. Management of glandular abnormalities
- Introduction
- Investigation of cytological glandular abnormalities
- Follow-up after excisional treatment for AIS
- Discussion
12. Screening in Aboriginal and Torres Strait Islander women
13. Screening after total hysterectomy
14. Screening in pregnancy
15. Screening in women who experienced early sexual intercourse or victims of sexual abuse
16. Screening in immune-deficient women
17. Screening in DES-exposed women
18. Signs and symptoms of cervical cancer
- Identification and investigation of abnormal bleeding
- Investigations of other symptoms – vaginal discharge and deep dyspareunia
19. Psychosocial care
20. Transition to the renewed National Cervical Screening Program
Appendices
- A. Modelled evaluation of predicted benefits, harms and cost-effectiveness of renewed NCSP in conjunction with recommendations
- B. Guidelines development process
- C. Clinical question list
- D. Technical report
- E. & F. Working party members and contributors
- G. Declarations of interest register
- H. Safety monitoring of the Renewed cervical screening program
- I. Glossary (terms and abbreviations)

Cervical cancer education modules (e-learning)

From Cancer Guidelines Wiki

National Cervical Screening Program: Guidelines for the management of screen-detected abnormalities, screening in specific populations and investigation of abnormal vaginal bleeding > Cervical cancer education modules (e-learning)

Jump to:navigation, search

Education modules available:

Education module for GPs, nurse Pap providers, sexual health physicians and general gynaecologists

Education module for professionals performing primary colposcopy

Cancer Council Australia wishes to acknowledge the contributions of Dr Louise Farrell and Professor Ian Hammond, who drafted the education module for professionals performing primary colposcopy; and Dr Stella Heley, Dr Lara Roeske, and Dr Joanne Mountford from VCS, who drafted the education module for GPs, nurse Pap providers, sexual health physicians and general gynaecologists.

Retrieved from "https://wiki.cancer.org.au/australiawiki/index.php?title=Guidelines:Cervical_cancer/Screening/E-learning&oldid=163421"